These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 35387563)
1. Fraxetin down-regulates polo-like kinase 4 (PLK4) to inhibit proliferation, migration and invasion of prostate cancer cells through the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathway. Ma Z; Sun Y; Peng W Bioengineered; 2022 Apr; 13(4):9345-9356. PubMed ID: 35387563 [TBL] [Abstract][Full Text] [Related]
2. PLK4 inhibitor plus bortezomib exhibits a synergistic effect on treating multiple myeloma via inactivating PI3K/AKT signaling. Xu B; Li J; Xu D; Ran Q Ir J Med Sci; 2023 Apr; 192(2):561-567. PubMed ID: 35508865 [TBL] [Abstract][Full Text] [Related]
3. Fraxetin inhibits proliferation and induces apoptosis of bladder cancer through the Akt pathway in vitro and in vivo. Weng M; Deng Z; Huang S; Lin X; Xu N; Sun X; Wu W; Lu J; Wang D J Biochem Mol Toxicol; 2024 Jan; 38(1):e23556. PubMed ID: 37867445 [TBL] [Abstract][Full Text] [Related]
4. Kaempferol inhibits proliferation, migration, and invasion of liver cancer HepG2 cells by down-regulation of microRNA-21. Zhu G; Liu X; Li H; Yan Y; Hong X; Lin Z Int J Immunopathol Pharmacol; 2018; 32():2058738418814341. PubMed ID: 30477356 [TBL] [Abstract][Full Text] [Related]
5. Fraxetin suppresses reactive oxygen species-dependent autophagy by the PI3K/Akt pathway to inhibit isoflurane-induced neurotoxicity in hippocampal neuronal cells. Zhang T; Zhou B; Sun J; Song J; Nie L; Zhu K J Appl Toxicol; 2022 Apr; 42(4):617-628. PubMed ID: 34553399 [TBL] [Abstract][Full Text] [Related]
6. Picropodophyllin Inhibits the Proliferation of Human Prostate Cancer DU145 and LNCaP Cells via ROS Production and PI3K/AKT Pathway Inhibition. Zhu X; Chen X; Wang G; Lei D; Chen X; Lin K; Li M; Lin H; Li D; Zheng Q Biol Pharm Bull; 2022; 45(8):1027-1035. PubMed ID: 35908886 [TBL] [Abstract][Full Text] [Related]
7. GPCR48/LGR4 promotes tumorigenesis of prostate cancer via PI3K/Akt signaling pathway. Liang F; Yue J; Wang J; Zhang L; Fan R; Zhang H; Zhang Q Med Oncol; 2015 Mar; 32(3):49. PubMed ID: 25636507 [TBL] [Abstract][Full Text] [Related]
8. GOLM1 promotes prostate cancer progression through activating PI3K-AKT-mTOR signaling. Yan G; Ru Y; Wu K; Yan F; Wang Q; Wang J; Pan T; Zhang M; Han H; Li X; Zou L Prostate; 2018 Feb; 78(3):166-177. PubMed ID: 29181846 [TBL] [Abstract][Full Text] [Related]
9. Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K/Akt pathway via Polo-like kinase 1. Mao Y; Xi L; Li Q; Cai Z; Lai Y; Zhang X; Yu C Oncol Rep; 2016 Jul; 36(1):49-56. PubMed ID: 27220401 [TBL] [Abstract][Full Text] [Related]
10. Sinodielide A exerts thermosensitizing effects and induces apoptosis and G2/M cell cycle arrest in DU145 human prostate cancer cells via the Ras/Raf/MAPK and PI3K/Akt signaling pathways. Hatashita M; Taniguchi M; Baba K; Koshiba K; Sato T; Jujo Y; Suzuki R; Hayashi S Int J Mol Med; 2014 Feb; 33(2):406-14. PubMed ID: 24285252 [TBL] [Abstract][Full Text] [Related]
11. Isorhamnetin inhibited the proliferation and metastasis of androgen-independent prostate cancer cells by targeting the mitochondrion-dependent intrinsic apoptotic and PI3K/Akt/mTOR pathway. Cai F; Zhang Y; Li J; Huang S; Gao R Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32039440 [TBL] [Abstract][Full Text] [Related]
12. [Crypotanshione reduces the expression of metadherin in DU145 prostate cancer cells]. Yao Y; Li HZ; Qian BJ; Liu CM; Zhang JB; Lin MC Zhonghua Nan Ke Xue; 2015 Sep; 21(9):782-7. PubMed ID: 26552209 [TBL] [Abstract][Full Text] [Related]
13. Combretastatin A4 Regulates Proliferation, Migration, Invasion, and Apoptosis of Thyroid Cancer Cells via PI3K/Akt Signaling Pathway. Liang W; Lai Y; Zhu M; Huang S; Feng W; Gu X Med Sci Monit; 2016 Dec; 22():4911-4917. PubMed ID: 27966519 [TBL] [Abstract][Full Text] [Related]
14. CircLMTK2 acts as a tumor suppressor in prostate cancer via regulating the expression of microRNA-183. Jin C; Zhao W; Zhang Z; Liu W Life Sci; 2020 Jan; 241():117097. PubMed ID: 31760099 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer. Ma T; Chen H; Wang P; Yang N; Bao J Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162 [No Abstract] [Full Text] [Related]
16. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway. Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655 [TBL] [Abstract][Full Text] [Related]
17. CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway. Li L; Hu Y; Chen D; Zhu J; Bao W; Xu X; Chen H; Chen W; Feng R Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34791506 [TBL] [Abstract][Full Text] [Related]
18. Breviscapine suppresses the growth and metastasis of prostate cancer through regulating PAQR4-mediated PI3K/Akt pathway. Ye J; Gao M; Guo X; Zhang H; Jiang F Biomed Pharmacother; 2020 Jul; 127():110223. PubMed ID: 32413672 [TBL] [Abstract][Full Text] [Related]
19. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells. Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210 [TBL] [Abstract][Full Text] [Related]
20. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling. Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]